Home › Funds › Morgan Creek Capital Management, LLC › REGN

Morgan Creek Capital Management, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Morgan Creek Capital Management, LLC reported holding 332 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$207K, representing 0.14% of its reported portfolio and ranking #14 among its reported holdings. Morgan Creek Capital Management, LLC has disclosed REGN holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)332 sh
Reported value held$207.01K
Portfolio Weight0.14%
First reportedQ4 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Morgan Creek Capital Management, LLC's REGN position evolved

Morgan Creek Capital Management, LLC first disclosed a stake in REGN in Q4 2025 at 276 shares (US$213K). Across 2 filings, Morgan Creek Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 332 shares valued at US$207K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 276 $213.04K New
Q2 2026 332 $207.01K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Morgan Creek Capital Management, LLC held REGN?

Morgan Creek Capital Management, LLC has disclosed REGN holdings in 2 of the last 3 reported quarters, going back to Q4 2025.

What is Morgan Creek Capital Management, LLC's current position in REGN?

As of Q2 2026, Morgan Creek Capital Management, LLC holds 332 shares of REGN (REGENERON PHARMACEUTICALS), valued at $207.01K, representing 0.14% of its reported portfolio and ranking #14.

Has Morgan Creek Capital Management, LLC been buying or selling REGN?

In the latest 13F filing (Q2 2026), Morgan Creek Capital Management, LLC newly opened its position in REGN.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.